Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m ...

AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO) Bringing more than ...

Compressed air is among the largest energy expenses in pharmaceutical manufacturing and must remain entirely ...

DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access ...

Axplora has announced plans to build a 4,500sqm R&D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy ...

Helus Pharma, a clinical stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs), has appointed ...

Ondine Biomedical has announced the North American phase 3 study has reached more than 93% enrolment, bringing the company ...

R1 Therapeutics has launched with an oversubscribed $77.5 million Series A financing and an exclusive global licence to ...

Qlaris Bio has appointed Fred Guerard as president and CEO. Guerard will also join the Board of Directors. Previously, ...

AlzeCure Pharma has released new preclinical findings for its lead Alzheimer’s drug candidate, NeuroRestore ACD856, following a presentation at the AD/PD 2026 international conference.

Early trial shows more than 50% LRRK2 reduction and supports expansion into other neurodegenerative conditions ...

Almirall has reported positive top-line results from its phase 3 ADorable-1 trial, which evaluated lebrikizumab in children ...